Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Pharyngeal Neoplasms 1Mouth Neoplasms 1Lip Neoplasms 1Head and Neck Neoplasms 1

Interventions

Cisplatin 98pembrolizumab 79Radiotherapy 49Carboplatin 41Magnetic Resonance Spectroscopy 37toripalimab 34Radiotherapy, Intensity-Modulated 34Gemcitabine 29Docetaxel 28Cetuximab 28Specimen Handling 26Surgical Procedures, Operative 23Paclitaxel 23Fluorouracil 22Radiation 20Nivolumab 20Biopsy 18Drug Therapy 17Chemoradiotherapy 17Blood Specimen Collection 17Capecitabine 15Standard of Care 14tislelizumab 13Surveys and Questionnaires 13Platinum 13camrelizumab 12nimotuzumab 11Immune Checkpoint Inhibitors 11130-nm albumin-bound paclitaxel 111,2-diaminocyclohexaneplatinum II citrate 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Metabolic Flux Analysis × Head & Neck × Clear all
NCT05837221 2026-02-24

Microbiome in Head and Neck Squamous Cell Carcinoma

University of Colorado, Denver

Recruiting
60 enrolled
Head & Neck

Head and Neck Neoplasms, Lip Neoplasms, Mouth Neoplasms, Pharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡